Form 4 for PRCT PROCEPT BioRobotics Corp
Accepted 2024-05-03 00:00:00 ET · period of report 2024-05-03 · accession 0001628280-24-020433 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-05-03 | 2024-05-03 | PRCT | Nouri Alaleh | EVP, CLO, CORP. SEC | S - Sale+OE | $62.97 | -30.4K | 62.6K | -33% | -$1.92M |
| DM | 2024-05-03 | 2024-05-03 | PRCT | Nouri Alaleh | EVP, CLO, CORP. SEC | M - OptEx | $6.87 | +30.4K | 63.9K | +91% | +$209.0K |
| DM | 2024-05-03 | 2024-05-03 | PRCT | Nouri Alaleh | EVP, CLO, CORP. SEC | M - OptEx | $0.00 | -30.4K | 16.2K | -65% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-03 | S | D | 391 | $60.84 | 92,513 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.67 to $60.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |
| 2 | Common | Common Stock | 2024-05-03 | S | D | 1,536 | $61.28 | 90,977 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.00 to $61.81, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |
| 3 | Common | Common Stock | 2024-05-03 | M | A | 25,000 | $7.27 | 92,904 | D | — | — | |
| 4 | Common | Common Stock | 2024-05-03 | M | A | 3,965 | $5.18 | 67,904 | D | — | — | |
| 5 | Common | Common Stock | 2024-05-03 | M | A | 1,467 | $4.56 | 63,939 | D | — | — | |
| 6 | Common | Common Stock | 2024-05-03 | S | D | 13,935 | $62.79 | 77,042 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.00 to $62.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |
| 7 | Common | Common Stock | 2024-05-03 | S | D | 133 | $64.04 | 62,472 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.02 to $64.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |
| 8 | Common | Common Stock | 2024-05-03 | S | D | 14,437 | $63.38 | 62,605 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.00 to $63.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |
| 9 | Derivative | Stock Option (Right to Buy) | 2024-05-03 | M | D | 1,467 | $0.00 | 12,230 | D | $4.56 · — to 2029-12-11 | 1,467 Common Stock | (F6) The Stock option was granted on December 12, 2019 and vests on each monthly anniversary of the grant date over a four year period, subject continued employment or service to the Issuer through the applicable vesting date. |
| 10 | Derivative | Stock Option (Right to Buy) | 2024-05-03 | M | D | 25,000 | $0.00 | 32,894 | D | $7.27 · — to 2031-06-21 | 25,000 Common Stock | (F8) The Stock option was granted on June 22, 2021 and vests 25% on the six month anniversary of June 22, 2021 and the remainder vests on each monthly anniversary over a four year period, subject continued employment or service to the Issuer through the applicable vesting date. |
| 11 | Derivative | Stock Option (Right to Buy) | 2024-05-03 | M | D | 3,965 | $0.00 | 16,160 | D | $5.18 · — to 2030-08-08 | 3,965 Common Stock | (F7) The Stock option was granted on August 10, 2020 and vests 12.5% on the six month anniversary of August 1, 2020 and the remainder on each monthly anniversary over a three and a half year period, subject continued employment or service to the Issuer through the applicable vesting date. |